Prognostic Nutritional Index as a Prognostic Indicator for the Occurrence of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

被引:2
作者
Zou, Wenbin [1 ]
Kuang, Wan [2 ]
Cai, Chun [1 ]
Qian, Yan [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[3] Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China
关键词
prognostic nutritional index; neoadjuvant immunochemotherapy; postoperative complications; esophageal squamous cell carcinoma; CHEMOTHERAPY; EFFICACY; OUTCOMES; CANCER; SAFETY; SCORE;
D O I
10.2147/CMAR.S465501
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background & Aims: The objective of this study was to evaluate the prognostic nutritional index (PNI) as a predictor of short-term postoperative complications in esophageal squamous cell carcinoma patients undergoing neoadjuvant immunochemotherapy. Methods: Clinical data were collected from 77 patients undergoing radical esophageal cancer surgery after neoadjuvant immunochemotherapy at Tongji Hospital from January 2022 to January 2023. The receiver operating characteristic curve (ROC) was utilized to establish the optimal cut-off point for the PNI. Subsequently, patients were stratified into low and high PNI groups according to this cut-off point, and comparisons were made between the two groups in terms of clinical data and postoperative complications. Results: Out of the 77 patients included in the study, 31 were categorized in the low PNI group and 46 in the high PNI group, with a defined cutoff point of 47.38. Significant statistical variances were noted in the occurrence rates of general complications (P < 0.001), pulmonary infections (P < 0.001), and anastomotic fistula (P = 0.034) between the two groups. The low PNI group displayed elevated rates of these complications in comparison to the high PNI group. Conclusion: The research findings indicate that preoperative nutritional assessment using the PNI can effectively predict short-term postoperative complications in esophageal squamous cell carcinoma patients who have undergone neoadjuvant therapy. Furthermore, the results suggest that implementing nutritional interventions for patients with moderate-to-severe malnutrition, as indicated by preoperative PNI evaluation, may help reduce the incidence of postoperative complications.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 26 条
[1]   PROGNOSTIC NUTRITIONAL INDEX IN GASTROINTESTINAL SURGERY [J].
BUZBY, GP ;
MULLEN, JL ;
MATTHEWS, DC ;
HOBBS, CL ;
ROSATO, EF .
AMERICAN JOURNAL OF SURGERY, 1980, 139 (01) :160-167
[2]   Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE) [J].
Duan, Hongtao ;
Shao, Changjian ;
Pan, Minghong ;
Liu, Honggang ;
Dong, Xiaoping ;
Zhang, Yong ;
Tong, Liping ;
Feng, Yingtong ;
Wang, Yuanyuan ;
Wang, Lu ;
Newman, Neil B. ;
Sarkaria, Inderpal S. ;
Reynolds, John V. ;
De Cobelli, Francesco ;
Ma, Zhiqiang ;
Jiang, Tao ;
Yan, Xiaolong .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[3]   Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma [J].
Feng, Ji-Feng ;
Chen, Qi-Xun .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 :1-7
[4]   Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis [J].
Hao, Jianqi ;
Chen, Cong ;
Wan, Fangfang ;
Zhu, Yuzhou ;
Jin, Hongyu ;
Zhou, Jian ;
Chen, Nan ;
Yang, Jing ;
Pu, Qiang .
FRONTIERS IN ONCOLOGY, 2020, 10 :1-10
[5]   Preoperative Prognostic Nutritional Index Predicts Long-Term Surgical Outcomes in Patients with Esophageal Squamous Cell Carcinoma [J].
Hirahara, Noriyuki ;
Tajima, Yoshitsugu ;
Fujii, Yusuke ;
Kaji, Shunsuke ;
Yamamoto, Tetsu ;
Hyakudomi, Ryoji ;
Taniura, Takahito ;
Miyazaki, Yoshiko ;
Kishi, Takashi ;
Kawabata, Yasunari .
WORLD JOURNAL OF SURGERY, 2018, 42 (07) :2199-2208
[6]   Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer [J].
Koppie, Theresa M. ;
Serio, Angel M. ;
Vickers, Andrew J. ;
Vora, Kinjal ;
Dalbagni, Guido ;
Donat, S. Machele ;
Herr, Harry W. ;
Bochner, Bernard H. .
CANCER, 2008, 112 (11) :2384-2392
[7]  
Li P, 2019, Medicine, V98, P22
[8]   Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma [J].
Liu, Jun ;
Yang, Yang ;
Liu, Zhichao ;
Fu, Xiaolong ;
Cai, Xiaoyue ;
Li, Hongxuan ;
Zhu, Li ;
Shen, Yan ;
Zhang, Hong ;
Sun, Yifeng ;
Chen, Hezhong ;
Yu, Bentong ;
Zhang, Renquan ;
Shao, Jinchen ;
Zhang, Ming ;
Li, Zhigang .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
[9]   Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study [J].
Liu, Jun ;
Li, Jingpei ;
Lin, Wanli ;
Shao, Di ;
Depypere, Lieven ;
Zhang, Zhifeng ;
Li, Zhuoyi ;
Cui, Fei ;
Du, Zesen ;
Zeng, Yuan ;
Jiang, Shunjun ;
He, Ping ;
Gu, Xia ;
Chen, Huai ;
Zhang, Hai ;
Lin, Xiaowei ;
Huang, Haoda ;
Lv, Wenqiang ;
Cai, Weiming ;
Liang, Wenhua ;
Liang, Hengrui ;
Jiang, Wenxi ;
Wang, Wei ;
Xu, Ke ;
Cai, Weipeng ;
Wu, Kui ;
Lerut, Toni ;
Fu, Junhui ;
He, Jianxing .
INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (01) :128-137
[10]   Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis [J].
Liu, Yunsong ;
Bao, Yongxing ;
Yang, Xu ;
Sun, Shuang ;
Yuan, Meng ;
Ma, Zeliang ;
Zhang, Wanting ;
Zhai, Yirui ;
Wang, Yang ;
Men, Yu ;
Qin, Jianjun ;
Xue, Liyan ;
Wang, Jun ;
Hui, Zhouguang .
FRONTIERS IN IMMUNOLOGY, 2023, 14